Portfolio Design Labs
EW icon

Portfolio Design Labs’s Edwards Lifesciences EW Stock Holding History

Portfolio Design Labs’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$236K Buy
2,732
+46
+2% +$4.09K 0.04% 207
2026
Q2 		$243K Buy
2,686
+18
+0.7% +$1.51K 0.04% 209
2026
Q1 		$214K Buy
+2,668
New +$220K 0.04% 227

Other funds holding EW

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Portfolio Design Labs's EW Position: Q3 2026 in Review

Portfolio Design Labs increased its Edwards Lifesciences (EW) stake by 1.7% in Q3 2026, buying an estimated $4.09K and bringing the position to 2,732 shares worth $236K. The position accounts for 0.04% of the portfolio, ranked #207.

Portfolio Design Labs first reported a position in EW in Q1 2026 and has held it in 3 quarters since. The position peaked at $243K in Q2 2026. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Portfolio Design Labs held 2,732 shares of Edwards Lifesciences worth $236K as of Q3 2026.
  • Portfolio Design Labs bought 46 Edwards Lifesciences shares in Q3 2026, an estimated $4.09K.
  • Edwards Lifesciences made up 0.04% of Portfolio Design Labs's portfolio in Q3 2026, its #207 holding.
  • Portfolio Design Labs first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 3 quarters since.
  • Portfolio Design Labs's Edwards Lifesciences position peaked at $243K in Q2 2026.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Portfolio Design Labs's 13F filing for Q3 2026, filed 4 Nov 2026.